Affordable medicines, preventing shortages and a climate-neutral industry – Parliament presses for a new EU pharmaceutical policy. During the plenary session in November 2021, the European Parlimanet set out a series of recommendations for the update of the EU’s pharmaceutical legislation. Faster access In 2019, the European Medicines Agency (EMA) authorised 103 orphan drugs – which are […]
Read More
Booster dose for people over 40 years old, elderly and vulnerable people – COVID-19
The European Centre for Disease Prevention and Control (ECDC) has issued a new report, in which it considers that the third dose should be applied 6 months after receiving the full course. The European Centre for Disease Prevention and Control (ECDC) has issued a new report, which assesses the risk of the population to […]
Read More
Europe recommends Covid-19 vaccination for children 5 to 11 years of age
The EMA’s Committee for Medicinal Products for Human Use (CHMP) has given the green light on Thursday to EU countries to vaccinate children between 5 and 11 years of age against Covid, considering that the benefits outweigh the risks, especially in children with health problems that increase the risk of serious disease. The Comirnaty vaccine, […]
Read More
MEPs say “no” to the Super League
The EU must shape a sporting model based on solidarity, inclusion, open competition and fairness, says a resolution adopted by MEPs on Tuesday. With 597 votes in favour, 36 against and 55 abstentions, MEPs backed a European sporting culture aligned with the EU’s values of solidarity, sustainability, inclusion, open competition, sporting merit and fairness. MEPs […]
Read More
EMA evaluating data on booster dose of COVID-19 Vaccine Janssen
EMA has started evaluating an application for the use of a booster dose of COVID-19 Vaccine Janssen to be given at least two months after the first dose to people aged 18 years and older. EMA’s human medicines committee (CHMP) will carry out an accelerated assessment of data submitted by the company that markets the vaccine. These […]
Read More
European Medicines Agency (EMA) gives go-ahead for use of anticovid tablet
The European Medicines Agency (EMA) gives the green light to the use of the anticovid pill that halves the risk of death and hospitalisation. The EMA’s Committee for Medicinal Products for Human Use (CHMP) has endorsed the use of Merk and Ridgeback’s ‘Lagevrio’ (molnupiravir) to treat Covid-19. With this approval, Merk takes the lead in the […]
Read More
Breast cancer predisposition genes exposed
Scientists know that a subset of genes are linked to familial breast cancer. However, this link has yet to be clearly determined or ruled out for many newly emerging genes. The FBC predisposition project aims to clear up remaining doubts. Of all women affected by breast cancer every year, 5 % to 10 % of […]
Read More
New EU farm to fork strategy to make our food healthier and more sustainable
MEPs present plans revamping the EU’s food systems, to produce healthier food, ensure food security, a fair income for farmers and reduce agriculture’s environmental footprint. Parliament welcomes the Farm to Fork strategy and underlines the importance of producing sustainable and healthy food to achieve the goals of the European Green Deal, including on climate, biodiversity, zero pollution […]
Read More
Coronavirus Present Situation in Africa – October
This document collects and analyses data on the evolution of COVID-19, collected by Johns Hopkins University and published daily by the European Documentation Centre of Almeria during the month of October 2021. COVID-19. Total data Africa Evolution of confirmed cases in Africa During the month of October, a total of 144,681 citizens were infected with […]
Read More